Hofmeister Robert 4
4 · TCR2 THERAPEUTICS INC. · Filed Dec 20, 2019
Insider Transaction Report
Form 4
Hofmeister Robert
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-12-19+50,000→ 50,000 totalExercise: $16.10Exp: 2029-12-18→ Common Stock (50,000 underlying)
Holdings
- 38,850
Common Stock
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on January 1, 2021, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.